Navigation Links
Carrington and Universal Harvest Sign Supply Agreement
Date:2/25/2008

- One-year Agreement With Guaranteed Purchase Minimums

- Carrington Provides Product Development, Manufacturing and Global

Distribution

IRVING, Texas, Feb. 25 /PRNewswire-FirstCall/ -- Carrington Laboratories, Inc. (OTC Bulletin Board: CARN) announced today it has signed a supply agreement with Universal Harvest Corporation of Nevada. Under the terms of this agreement, Carrington will provide Universal Harvest with product development, manufacturing and packaging services. The agreement provides guaranteed revenues, on a quarterly basis, for 2008.

The product covered under this agreement will contain a proprietary raw material from Carrington's Costa Rican subsidiary Sabila Industrial. Sabila Industrial will also be involved in manufacturing of the finished product for international users.

Doug Golwas, Carrington's vice president, corporate sales and marketing, stated, "Carrington is focused on aggressively marketing our ISO-certified, cGMP liquid filling capabilities. We have a long history of providing a quality and geographic advantage for our customers for these types of services. This agreement is evidence that the market finds strategic and economic value in this segment of our business."

Both parties have agreed to enter into discussions for a long-term extension prior to the expiration of the agreement.

About Carrington

Carrington Laboratories, Inc. is an ISO 9001-certified, research-based, biopharmaceutical and consumer products company currently utilizing naturally-occurring complex carbohydrates to manufacture and market products for mucositis, radiation dermatitis, wound and oral care, as well as to manufacture and market the nutraceutical raw material Manapol(R) and cosmetic raw material Hydrapol(TM). Carrington also manufactures and markets consumer products and manufactures quality products for other companies. Manufacturing operations comply with cGMP stan
'/>"/>

SOURCE Carrington Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Carrington Subsidiary DelSite Starts Making Test Batches of First Bird Flu Vaccine Offering Needle-free Self-Administration
2. Carrington Settles Lawsuit, Sets Sights On Future
3. Carrington Retains Milkie/Ferguson to Explore Financial Alternatives
4. Carrington Reports Third Quarter 2007 Results
5. Carrington Reports on ISO 9001:2000 Inspection
6. Carrington Laboratories Common Stock Now Trading on the OTC Bulletin Board: CARN.OB
7. Carrington and DaySpring Pharma Extend and Formalize Agreement for Distribution of Diabetic and Radiation Products Into Physician Market
8. Carrington Subsidiary DelSite Biotechnologies Enters into Technology Evaluation Rights License Agreement for Transdermal Delivery of Vaccines
9. Carrington Reports on ISO 9001:2000 Inspection at Sabila Industrial in Costa Rica
10. Carrington Completes $8 Million Financing
11. Carrington Reports Second Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Wisc. (PRWEB) May 21, 2013 ... parts distributor , will be exhibiting for the ... Advancement of Medical Instrumentation (AAMI) 2013 Conference and ... purchase, support, distribute, and manufacture healthcare technologies. This ... in Long Beach, California. , The three-day ...
(Date:5/21/2013)... NC (PRWEB) May 21, 2013 ... financial services company for clinical trials, announced today ... Spend Solutions, LLC. Clinverse’s ClinPay® FLS eClinical ... investigator payment process. SpendMD ™, Aggregate ... complete solution for tracking and reporting transfer of ...
(Date:5/21/2013)... Canada (PRWEB) May 21, 2013 ... is a strong push within the industry to ... and Manufacturing Organizations and pharma companies often means ... frames. , Microtablets, developed in collaboration with Sensidose ... effective outsourcing can bring products to market sooner. ...
(Date:5/21/2013)... , May 21, 2013  MacroGenics, Inc. today ... of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody ... the HER2 oncoprotein," will be presented at the ... Clinical Oncology during the Developmental Therapeutics - Immunotherapy ... 4:15 – 4:30 PM.  The presentation will describe ...
Breaking Biology Technology:Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
... Sciences presented their latest biological results supporting the ... compound for the treatment of solid tumors at ... British Columbia. The presentation highlighted advances in the ... piperazines demonstrate potent antiproliferative activity against a variety ...
... Gene Therapy in Cardiac Disease (CUPID Trial) Demonstrated ... Using Gene TransferSAN DIEGO, April 8 Celladon ... a Phase 1/2 trial of MYDICAR(R) (AAV1/SERCA2a), a ... failure, in the April 2009 issue of the ...
... DNA sequencing technology company, announced a definitive agreement ... investment in the company. Prompting its decision was ... reversible terminator chemistry, Lightning Terminators (TM), for ... chemistry as reagent kits to the market as ...
Cached Biology Technology:ImQuest Presentation at Keystone Symposium Focuses on Advancements in Their Cancer Research and Development Program 2The Journal of Cardiac Failure Publishes Results From Celladon Corporation's First-in-Human Phase 1/2 Clinical Trial in Advanced Heart Failure 2The Journal of Cardiac Failure Publishes Results From Celladon Corporation's First-in-Human Phase 1/2 Clinical Trial in Advanced Heart Failure 3SeqWright to Invest in LaserGen's Novel Lightning Terminators(TM) 2
(Date:5/22/2013)... that can detect molecular variants in chemical mixtures ... most important, though time-consuming, processes in analytical chemistry. ... , post-doctoral researcher David Patterson, Professor of Physics John ... Free-Electron Laser Science (CFEL) in Hamburg, Germany developed a ... molecular variants apart, and to determine how much variant ...
(Date:5/22/2013)... in a major new effort to educate the public ... people with clean water that looms ahead in the ... in the current edition of Chemical & Engineering ... Society (ACS), the world,s largest scientific society. , Bassam ... L. Schnoor, Ph.D., explain that shortages of reliable supplies ...
(Date:5/22/2013)... (May 22, 2013)The omega 3 fatty acids in fish ... diseaseso much so that the American Heart Association currently ... week, particularly fatty varieties rich in omega 3s. However, ... mystery. In a new study, scientists led by Jason ... this phenomenon by providing evidence that fish oil might ...
Breaking Biology News(10 mins):Detecting mirror molecules 2Detecting mirror molecules 3Fish oil may help the heart beat mental stress 2
... expert in the design of low-rise buildings for ... at the Annual Conference of Construction Specifications Canada ... Taher, a university lecturer in NJIT,s College of ... engineer, http://www.njit.edu/news/experts/taher.php . Construction Specifications Canada ...
... release is available in German . ... the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is to establish ... the appropriate Grants Committee in Bonn. The new institutions will ... years, during which time they will receive total funding of ...
... 19 May 2011. The research vessel Polarstern of the ... the Helmholtz Association will arrive back at its homeport ... May. Nearly 200 researchers from institutes in 15 countries ... conducted measurements showing that warming of the water in ...
Cached Biology News:Better buildings for extreme climates will be focus of researcher's talk 2DFG establishes 18 new research training groups 2DFG establishes 18 new research training groups 3DFG establishes 18 new research training groups 4DFG establishes 18 new research training groups 5DFG establishes 18 new research training groups 6DFG establishes 18 new research training groups 7DFG establishes 18 new research training groups 8DFG establishes 18 new research training groups 9DFG establishes 18 new research training groups 10Research ship Polarstern returns from Antartica 2Research ship Polarstern returns from Antartica 3
... (AMV RT) catalyzes the polymerization of DNA ... (1). It requires a primer (DNA primers ... well as Mg2+ or Mn2+. The enzyme ... nonionic detergents and sulfhydryl compounds stabilize the ...
... - Neurosphere is a system designed for ... neurospheres in a serum free environment. The kit ... which has been optimized for neural stem cell ... Genes & Development 10 :3129). Two growth ...
DNase I (Deoxyribonuclease I) digests single- and double-stranded DNA to oligodeoxyribonucleotides. Ribonuclease activity has been reduced to non-detectable levels....
... coli strain containing an overproducing clone of ... Transcriptase catalyzes the polymerization of DNA using ... copies of large mRNAs, >10 kb, may ... much lower RNase H activity than AMV ...
Biology Products: